ORDER

Resources

  • All
  • Pfenex Press Releases
  • Pfenex Case Studies
  • Other Resources

Merck Vaccine using Pfenex CRM197 has BLA Accepted for Review by FDA

Ligand Pharmaceuticals Incorporated
01/13/2021

Pfenex Acquired by Ligand Pharmaceuticals

Ligand Pharmaceuticals Incorporated
10/01/2020

CRM197 Data Sheet

Pfenex

Pfenex Licensee receives Advance Market Commitment award for pneumococcal vaccine supply

PATH
06/18/2020

Serum Institute of India Private Limited has achieved World Health Organization (WHO) prequalification for PNEUMOSIL®, containing CRM197 produced in Pfenex Expression Technology

Pfenex Press Release
01/07/2020

Pfenex Licensee Begins Pivotal Phase 3 Study for Meningococcal ACWXY Conjugate Vaccine

PATH
09/01/2019

Pfenex Reports Increased CRM197 Sales in Q1 2019

Pfenex Press Release
05/14/2019

Pfenex CRM197 is More Immunogenic than KLH in Mice

Pfenex Case Study

Pfenex Licensee Succesfully Completes a Phase 3 Study and Enters Registration for Pneumosil®

Pfenex Press Release
03/06/2019

Pfenex Receives Milestone From Merck Associated With Clinical Advancement of Investigational 15-valent Pneumococcal Vaccine PCV-15 (V114)

Pfenex Press Release
07/12/2018

Analytical Assessment Shows Pfenex CRM197 has Highest Purity

ScienceDirect.com | By: John M. Hickey, et al.
07/01/2018

Dedicated Facility Injects CRM197 Into Conjugate Vaccine Market

in-Pharma Technologist | By: Dan Stanton
01/21/2013

Pfenex Division Begins Product Capacity Expansion

Genetic Engineering & Biotechnology News
01/16/2013

Choose a Commercial-Scale, Secure Supply Chain with Pfenex CRM197

Pfenex Case Study

Pfenex Inc., Through Its Reagent Proteins Division, Announces Capacity Expansion for cGMP CRM197 Production

Pfenex Press Release
01/16/2013

Recombinant Production of Carrier Proteins

Genetic Engineering & Biotechnology News
12/01/2012

Carrier Protein Outsourcing

BioProcess International | Cassidy Brady, Kevin Killeen, William Taylor and Anant Patkar
11/01/2012

Pfenex Inc., Through Its Reagent Proteins Business Division, Announces Submission of Biologics Master File for Recombinant CRM197 to US FDA

Pfenex Press Release
05/17/2011

Pfenex Inc., Through its Reagent Proteins Business Division, Establishes Clinical Supply Agreement With Henry M. Jackson Foundation for the Advancement of Military Medicine

Pfenex Press Release
11/30/2010

Events

TBD